Divi's Laboratories Limited

Divi's Laboratories Limited (DIVISLAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

HealthcareHealthcarePharmaceuticals & BiotechnologyPharmaceuticals

divislabs.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹9220.00
Market cap
2,44,961 Cr
Stock P/E
83.7
P/B
14.59
Dividend yield
0.3%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,909 Cr1,855 Cr2,303 Cr2,118 Cr2,338 Cr2,319 Cr2,585 Cr2,410 Cr2,715 Cr2,604 Cr2,831 Cr3,080 Cr
Operating expenses (approx.)1,430 Cr1,366 Cr1,572 Cr1,496 Cr1,622 Cr1,576 Cr1,699 Cr1,681 Cr1,827 Cr1,714 Cr1,897 Cr1,825 Cr
EBITDA479 Cr489 Cr731 Cr622 Cr716 Cr743 Cr886 Cr729 Cr888 Cr890 Cr934 Cr1,255 Cr
OPM %25.1%26.4%31.7%29.4%30.6%32.0%34.3%30.2%32.7%34.2%33.0%40.7%
Other income86 Cr95 Cr79 Cr79 Cr106 Cr82 Cr86 Cr119 Cr145 Cr88 Cr155 Cr64 Cr
Interest1 Cr0 Cr2 Cr0 Cr1 Cr0 Cr1 Cr3 Cr8 Cr6 Cr6 Cr6 Cr
Depreciation95 Cr95 Cr95 Cr97 Cr99 Cr99 Cr107 Cr112 Cr113 Cr118 Cr120 Cr133 Cr
Profit before tax469 Cr489 Cr713 Cr604 Cr722 Cr726 Cr864 Cr733 Cr912 Cr780 Cr963 Cr1,180 Cr
Tax %25.8%26.8%24.5%28.8%29.4%18.9%23.4%25.6%24.5%25.3%22.0%23.6%
Net profit348 Cr358 Cr538 Cr430 Cr510 Cr589 Cr662 Cr545 Cr689 Cr583 Cr751 Cr902 Cr
EPS (₹)₹13.11₹13.50₹20.25₹16.20₹19.20₹22.20₹24.93₹20.49₹25.97₹21.98₹28.31₹33.95

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4,946 Cr5,394 Cr6,969 Cr8,960 Cr7,768 Cr7,845 Cr9,360 Cr10,560 CrSign in for TTM
Operating expenses (approx.)3,074 Cr3,572 Cr4,109 Cr5,078 Cr5,400 Cr5,640 Cr6,392 Cr7,119 CrSign in for TTM
EBITDA1,872 Cr1,822 Cr2,860 Cr3,882 Cr2,368 Cr2,205 Cr2,968 Cr3,441 CrSign in for TTM
OPM %37.8%33.8%41.0%43.3%30.5%28.1%31.7%32.6%Sign in for TTM
Other income156 Cr190 Cr63 Cr114 Cr345 Cr339 Cr352 Cr507 CrSign in for TTM
Interest4 Cr6 Cr0.87 Cr0.80 Cr0.67 Cr3 Cr2 Cr23 CrSign in for TTM
Depreciation169 Cr186 Cr256 Cr312 Cr343 Cr378 Cr402 Cr463 CrSign in for TTM
Profit before tax1,855 Cr1,819 Cr2,666 Cr3,684 Cr2,369 Cr2,163 Cr2,916 Cr3,388 CrSign in for TTM
Tax %27.1%24.3%25.6%19.6%23.0%26.0%24.9%24.2%Sign in for TTM
Net profit1,353 Cr1,377 Cr1,984 Cr2,960 Cr1,823 Cr1,600 Cr2,191 Cr2,568 CrSign in for TTM
EPS (₹)₹50.96₹51.85₹74.75₹111.52₹68.69₹60.27₹82.53₹96.75Sign in for TTM
Dividend payout %17.9%43.7%49.8%36.3%31.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital53 Cr53 Cr53 Cr53 Cr53 Cr53 Cr53 Cr53 Cr
Reserves6,904 Cr7,257 Cr9,242 Cr11,675 Cr12,714 Cr13,518 Cr14,916 Cr16,708 Cr
Borrowings106 Cr34 Cr0.35 Cr2 Cr
Other liabilities975 Cr1,192 Cr1,479 Cr1,647 Cr1,672 Cr1,899 Cr1,961 Cr3,272 Cr
Total liabilities8,038 Cr8,536 Cr10,774 Cr13,375 Cr14,439 Cr15,470 Cr16,932 Cr20,033 Cr
Fixed assets (net)2,084 Cr2,773 Cr3,699 Cr4,314 Cr4,714 Cr4,733 Cr5,437 Cr6,515 Cr
CWIP492 Cr920 Cr711 Cr470 Cr212 Cr778 Cr1,022 Cr2,113 Cr
Investments1,946 Cr971 Cr0.01 Cr72 Cr77 Cr82 Cr65 Cr69 Cr
Loans & advances0.11 Cr0.09 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories1,772 Cr1,864 Cr2,145 Cr2,829 Cr3,000 Cr3,184 Cr3,236 Cr3,954 Cr
Trade receivables1,163 Cr1,413 Cr1,677 Cr2,424 Cr1,793 Cr2,156 Cr2,731 Cr2,984 Cr
Cash & bank13 Cr43 Cr2,030 Cr1,215 Cr170 Cr363 Cr415 Cr128 Cr
Other assets568 Cr551 Cr512 Cr2,051 Cr4,473 Cr4,174 Cr4,026 Cr4,270 Cr
Total assets8,038 Cr8,536 Cr10,774 Cr13,375 Cr14,439 Cr15,470 Cr16,932 Cr20,033 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity1,912 Cr2,460 Cr1,261 Cr1,653 Cr2,738 Cr
Cash from investing-2,195 Cr-2,708 Cr-269 Cr-804 Cr-2,219 Cr
Cash from financing-532 Cr-797 Cr-799 Cr-799 Cr-804 Cr
Net cash flow-816 Cr-1,045 Cr193 Cr50 Cr-285 Cr
Free cash flow (OCF − Capex)1,199 Cr1,987 Cr258 Cr215 Cr218 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %26.7%25.0%28.7%31.4%18.6%16.0%19.5%20.4%
ROE %0.0%18.8%21.3%25.2%14.3%11.8%14.6%15.3%
Debtor days8696889884100106103
Inventory days307309326296363360308329
Days payable859811683929387101
Cash conversion cycle307307297311355367328331
Debt / equity0.020.00460.00000.0001
Current ratio5.495.055.556.998.467.576.945.43
Net debt / EBITDA0.000.000.000.00-0.07-0.16-0.14-0.04

Compare with peers

Loading peers…